Medy-Tox Inc. 086900.KQ Stock
Medy-Tox Inc. Price Chart
Medy-Tox Inc. 086900.KQ Financial and Trading Overview
Medy-Tox Inc. stock price | 134400 KRW |
Previous Close | 262000 KRW |
Open | 258500 KRW |
Bid | 257000 KRW x 0 |
Ask | 257500 KRW x 0 |
Day's Range | 255000 - 265500 KRW |
52 Week Range | 94952.38 - 281000 KRW |
Volume | 127.33K KRW |
Avg. Volume | 163.67K KRW |
Market Cap | 1.4T KRW |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 KRW |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 260476 KRW |
086900.KQ Valuation Measures
Enterprise Value | 2.15T KRW |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | -1.83 |
Price/Sales (ttm) | 7.0791783 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 10.845 |
Enterprise Value/EBITDA | 37.376 |
Trading Information
Medy-Tox Inc. Stock Price History
Beta (5Y Monthly) | N/A |
52-Week Change | 151.00% |
S&P500 52-Week Change | 20.43% |
52 Week High | 281000 KRW |
52 Week Low | 94952.38 KRW |
50-Day Moving Average | 244970 KRW |
200-Day Moving Average | 165682.4 KRW |
086900.KQ Share Statistics
Avg. Volume (3 month) | 163.67K KRW |
Avg. Daily Volume (10-Days) | 168.68K KRW |
Shares Outstanding | 5.44M |
Float | 5.82M |
Short Ratio | N/A |
% Held by Insiders | 23.60% |
% Held by Institutions | 9.26% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | N/A |
Trailing Annual Dividend Yield | N/A |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor | 1.05:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 18.94% |
Operating Margin (ttm) | 21.69% |
Gross Margin | 63.45% |
EBITDA Margin | 29.01% |
Management Effectiveness
Return on Assets (ttm) | 4.46% |
Return on Equity (ttm) | 8.33% |
Income Statement
Revenue (ttm) | 198.01B KRW |
Revenue Per Share (ttm) | 29654.77 KRW |
Quarterly Revenue Growth (yoy) | 7.29% |
Gross Profit (ttm) | 126.05B KRW |
EBITDA | 57.45B KRW |
Net Income Avi to Common (ttm) | 36.55B KRW |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | 10.10% |
Balance Sheet
Total Cash (mrq) | 42.69B KRW |
Total Cash Per Share (mrq) | 5374.09 KRW |
Total Debt (mrq) | 99.37B KRW |
Total Debt/Equity (mrq) | 21.43 KRW |
Current Ratio (mrq) | 1.328 |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | 13.91B KRW |
Levered Free Cash Flow (ttm) | -21539180544 KRW |
Profile of Medy-Tox Inc.
Country | South Korea |
State | N/A |
City | Cheongju |
Address | 78, Gak-ri 1-gi |
ZIP | N/A |
Phone | 82 4 3217 1555 |
Website | https://www.medy-tox.co.kr |
Industry | |
Sector(s) | |
Full Time Employees | N/A |
Medy-Tox Inc. operates as a biopharmaceutical company in South Korea. It provides botulinum toxin products, including Neuronox, a lyophilized white power for injection that is used to treat foot deformities due to spasticity in pediatric cerebral palsy patients; INNOTOX, a colorless transparent liquid-filled injection that is used to temporarily improve moderate to severe glabellar wrinkles; and Coretox, a lyophilized white power for injection that is used to temporarily improve moderate to severe glabellar wrinkles. The company also offers hyaluronic acid filler products comprising Neuramis and Potenfill that are tissue recovering biomaterials. In addition, it provides various medical devices, such as ComfortDual and Recell Ice for tissue coagulation by using high-frequency current; Neurajet Plus to assist injecting other pharmaceuticals; Carewave for improving erectile dysfunction by using low-intensity shock wave generated from the electromagnetic method; and Careveam for treating skin ailment by using ultraviolet light. Further, the company offers Neurakin cream for acute eczema, contact dermatitis, atopic dermatitis, chronic eczema, rosacea dermatitis, perioral dermatitis, herpes zoster, and acne vulgaris. It also exports its products to approximately 60 countries, including Japan, Thailand, and Brazil. Medytox, Inc. has partnership with Dyadic International, Inc. to develop vaccines against COVID-19 variants. The company was founded in 2000 and is headquartered in Cheongju, South Korea.
Q&A For Medy-Tox Inc. Stock
What is a current 086900.KQ stock price?
Medy-Tox Inc. 086900.KQ stock price today per share is 134400 KRW.
How to purchase Medy-Tox Inc. stock?
You can buy 086900.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Medy-Tox Inc.?
The stock symbol or ticker of Medy-Tox Inc. is 086900.KQ.
How many shares does Medy-Tox Inc. have in circulation?
The max supply of Medy-Tox Inc. shares is 6.73M.
What is Medy-Tox Inc. Price to Earnings Ratio (PE Ratio)?
Medy-Tox Inc. PE Ratio is now.
What was Medy-Tox Inc. earnings per share over the trailing 12 months (TTM)?
Medy-Tox Inc. EPS is 0 KRW over the trailing 12 months.